Pharmaceutical and Medical Device Sector Guidance for Product Life Cycle Accounting

The United Kingdom National Health Service’s guidance document for pharmaceutical products and medical devices has been finalized. This document was developed following the methodology of the GHG Protocol Product Life Cycle Accounting and Reporting Standard and has received the GHG Protocol Built on Mark. More information is available here.











Documents
Guidance Document - Pharmaceutical Product and Medical Device GHG Accounting - November 2012
Summary Document - Pharmaceutical Product and Medical Device GHG Accounting - November 2012